The global Botulinum Neurotoxins market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Johnson & Johnson
GSK
Allergan
Chong Kun Dang
Eisai
Nestle
Galderma
Ipsen
Hugel
Mentor
CROMA
Alphaeon
OBI Pharma
Revance Therapeutics
Daewoong Pharmaceutical
Medy-Tox
EpiVax
Anterios
Escape Therapeutics
Lipella
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Transdermal
Valeant Pharmaceuticals
CNBG
By Types:
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)
By Applications:
Medical Uses
Cosmetics
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Botulinum Neurotoxins Market Size Analysis from 2023 to 2028
1.5.1 Global Botulinum Neurotoxins Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Botulinum Neurotoxins Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Botulinum Neurotoxins Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Botulinum Neurotoxins Industry Impact
Chapter 2 Global Botulinum Neurotoxins Competition by Types, Applications, and Top Regions and Countries
2.1 Global Botulinum Neurotoxins (Volume and Value) by Type
2.1.1 Global Botulinum Neurotoxins Consumption and Market Share by Type (2017-2022)
2.1.2 Global Botulinum Neurotoxins Revenue and Market Share by Type (2017-2022)
2.2 Global Botulinum Neurotoxins (Volume and Value) by Application
2.2.1 Global Botulinum Neurotoxins Consumption and Market Share by Application (2017-2022)
2.2.2 Global Botulinum Neurotoxins Revenue and Market Share by Application (2017-2022)
2.3 Global Botulinum Neurotoxins (Volume and Value) by Regions
2.3.1 Global Botulinum Neurotoxins Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Botulinum Neurotoxins Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Botulinum Neurotoxins Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Botulinum Neurotoxins Consumption by Regions (2017-2022)
4.2 North America Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
4.10 South America Botulinum Neurotoxins Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Botulinum Neurotoxins Market Analysis
5.1 North America Botulinum Neurotoxins Consumption and Value Analysis
5.1.1 North America Botulinum Neurotoxins Market Under COVID-19
5.2 North America Botulinum Neurotoxins Consumption Volume by Types
5.3 North America Botulinum Neurotoxins Consumption Structure by Application
5.4 North America Botulinum Neurotoxins Consumption by Top Countries
5.4.1 United States Botulinum Neurotoxins Consumption Volume from 2017 to 2022
5.4.2 Canada Botulinum Neurotoxins Consumption Volume from 2017 to 2022
5.4.3 Mexico Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 6 East Asia Botulinum Neurotoxins Market Analysis
6.1 East Asia Botulinum Neurotoxins Consumption and Value Analysis
6.1.1 East Asia Botulinum Neurotoxins Market Under COVID-19
6.2 East Asia Botulinum Neurotoxins Consumption Volume by Types
6.3 East Asia Botulinum Neurotoxins Consumption Structure by Application
6.4 East Asia Botulinum Neurotoxins Consumption by Top Countries
6.4.1 China Botulinum Neurotoxins Consumption Volume from 2017 to 2022
6.4.2 Japan Botulinum Neurotoxins Consumption Volume from 2017 to 2022
6.4.3 South Korea Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 7 Europe Botulinum Neurotoxins Market Analysis
7.1 Europe Botulinum Neurotoxins Consumption and Value Analysis
7.1.1 Europe Botulinum Neurotoxins Market Under COVID-19
7.2 Europe Botulinum Neurotoxins Consumption Volume by Types
7.3 Europe Botulinum Neurotoxins Consumption Structure by Application
7.4 Europe Botulinum Neurotoxins Consumption by Top Countries
7.4.1 Germany Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.2 UK Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.3 France Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.4 Italy Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.5 Russia Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.6 Spain Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.7 Netherlands Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.8 Switzerland Botulinum Neurotoxins Consumption Volume from 2017 to 2022
7.4.9 Poland Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 8 South Asia Botulinum Neurotoxins Market Analysis
8.1 South Asia Botulinum Neurotoxins Consumption and Value Analysis
8.1.1 South Asia Botulinum Neurotoxins Market Under COVID-19
8.2 South Asia Botulinum Neurotoxins Consumption Volume by Types
8.3 South Asia Botulinum Neurotoxins Consumption Structure by Application
8.4 South Asia Botulinum Neurotoxins Consumption by Top Countries
8.4.1 India Botulinum Neurotoxins Consumption Volume from 2017 to 2022
8.4.2 Pakistan Botulinum Neurotoxins Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Botulinum Neurotoxins Market Analysis
9.1 Southeast Asia Botulinum Neurotoxins Consumption and Value Analysis
9.1.1 Southeast Asia Botulinum Neurotoxins Market Under COVID-19
9.2 Southeast Asia Botulinum Neurotoxins Consumption Volume by Types
9.3 Southeast Asia Botulinum Neurotoxins Consumption Structure by Application
9.4 Southeast Asia Botulinum Neurotoxins Consumption by Top Countries
9.4.1 Indonesia Botulinum Neurotoxins Consumption Volume from 2017 to 2022
9.4.2 Thailand Botulinum Neurotoxins Consumption Volume from 2017 to 2022
9.4.3 Singapore Botulinum Neurotoxins Consumption Volume from 2017 to 2022
9.4.4 Malaysia Botulinum Neurotoxins Consumption Volume from 2017 to 2022
9.4.5 Philippines Botulinum Neurotoxins Consumption Volume from 2017 to 2022
9.4.6 Vietnam Botulinum Neurotoxins Consumption Volume from 2017 to 2022
9.4.7 Myanmar Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 10 Middle East Botulinum Neurotoxins Market Analysis
10.1 Middle East Botulinum Neurotoxins Consumption and Value Analysis
10.1.1 Middle East Botulinum Neurotoxins Market Under COVID-19
10.2 Middle East Botulinum Neurotoxins Consumption Volume by Types
10.3 Middle East Botulinum Neurotoxins Consumption Structure by Application
10.4 Middle East Botulinum Neurotoxins Consumption by Top Countries
10.4.1 Turkey Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.3 Iran Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.5 Israel Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.6 Iraq Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.7 Qatar Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.8 Kuwait Botulinum Neurotoxins Consumption Volume from 2017 to 2022
10.4.9 Oman Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 11 Africa Botulinum Neurotoxins Market Analysis
11.1 Africa Botulinum Neurotoxins Consumption and Value Analysis
11.1.1 Africa Botulinum Neurotoxins Market Under COVID-19
11.2 Africa Botulinum Neurotoxins Consumption Volume by Types
11.3 Africa Botulinum Neurotoxins Consumption Structure by Application
11.4 Africa Botulinum Neurotoxins Consumption by Top Countries
11.4.1 Nigeria Botulinum Neurotoxins Consumption Volume from 2017 to 2022
11.4.2 South Africa Botulinum Neurotoxins Consumption Volume from 2017 to 2022
11.4.3 Egypt Botulinum Neurotoxins Consumption Volume from 2017 to 2022
11.4.4 Algeria Botulinum Neurotoxins Consumption Volume from 2017 to 2022
11.4.5 Morocco Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 12 Oceania Botulinum Neurotoxins Market Analysis
12.1 Oceania Botulinum Neurotoxins Consumption and Value Analysis
12.2 Oceania Botulinum Neurotoxins Consumption Volume by Types
12.3 Oceania Botulinum Neurotoxins Consumption Structure by Application
12.4 Oceania Botulinum Neurotoxins Consumption by Top Countries
12.4.1 Australia Botulinum Neurotoxins Consumption Volume from 2017 to 2022
12.4.2 New Zealand Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 13 South America Botulinum Neurotoxins Market Analysis
13.1 South America Botulinum Neurotoxins Consumption and Value Analysis
13.1.1 South America Botulinum Neurotoxins Market Under COVID-19
13.2 South America Botulinum Neurotoxins Consumption Volume by Types
13.3 South America Botulinum Neurotoxins Consumption Structure by Application
13.4 South America Botulinum Neurotoxins Consumption Volume by Major Countries
13.4.1 Brazil Botulinum Neurotoxins Consumption Volume from 2017 to 2022
13.4.2 Argentina Botulinum Neurotoxins Consumption Volume from 2017 to 2022
13.4.3 Columbia Botulinum Neurotoxins Consumption Volume from 2017 to 2022
13.4.4 Chile Botulinum Neurotoxins Consumption Volume from 2017 to 2022
13.4.5 Venezuela Botulinum Neurotoxins Consumption Volume from 2017 to 2022
13.4.6 Peru Botulinum Neurotoxins Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Botulinum Neurotoxins Consumption Volume from 2017 to 2022
13.4.8 Ecuador Botulinum Neurotoxins Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Botulinum Neurotoxins Business
14.1 Johnson & Johnson
14.1.1 Johnson & Johnson Company Profile
14.1.2 Johnson & Johnson Botulinum Neurotoxins Product Specification
14.1.3 Johnson & Johnson Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 GSK
14.2.1 GSK Company Profile
14.2.2 GSK Botulinum Neurotoxins Product Specification
14.2.3 GSK Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Allergan
14.3.1 Allergan Company Profile
14.3.2 Allergan Botulinum Neurotoxins Product Specification
14.3.3 Allergan Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Chong Kun Dang
14.4.1 Chong Kun Dang Company Profile
14.4.2 Chong Kun Dang Botulinum Neurotoxins Product Specification
14.4.3 Chong Kun Dang Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Eisai
14.5.1 Eisai Company Profile
14.5.2 Eisai Botulinum Neurotoxins Product Specification
14.5.3 Eisai Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Nestle
14.6.1 Nestle Company Profile
14.6.2 Nestle Botulinum Neurotoxins Product Specification
14.6.3 Nestle Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Galderma
14.7.1 Galderma Company Profile
14.7.2 Galderma Botulinum Neurotoxins Product Specification
14.7.3 Galderma Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Ipsen
14.8.1 Ipsen Company Profile
14.8.2 Ipsen Botulinum Neurotoxins Product Specification
14.8.3 Ipsen Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Hugel
14.9.1 Hugel Company Profile
14.9.2 Hugel Botulinum Neurotoxins Product Specification
14.9.3 Hugel Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Mentor
14.10.1 Mentor Company Profile
14.10.2 Mentor Botulinum Neurotoxins Product Specification
14.10.3 Mentor Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 CROMA
14.11.1 CROMA Company Profile
14.11.2 CROMA Botulinum Neurotoxins Product Specification
14.11.3 CROMA Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Alphaeon
14.12.1 Alphaeon Company Profile
14.12.2 Alphaeon Botulinum Neurotoxins Product Specification
14.12.3 Alphaeon Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 OBI Pharma
14.13.1 OBI Pharma Company Profile
14.13.2 OBI Pharma Botulinum Neurotoxins Product Specification
14.13.3 OBI Pharma Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Revance Therapeutics
14.14.1 Revance Therapeutics Company Profile
14.14.2 Revance Therapeutics Botulinum Neurotoxins Product Specification
14.14.3 Revance Therapeutics Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Daewoong Pharmaceutical
14.15.1 Daewoong Pharmaceutical Company Profile
14.15.2 Daewoong Pharmaceutical Botulinum Neurotoxins Product Specification
14.15.3 Daewoong Pharmaceutical Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Medy-Tox
14.16.1 Medy-Tox Company Profile
14.16.2 Medy-Tox Botulinum Neurotoxins Product Specification
14.16.3 Medy-Tox Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 EpiVax
14.17.1 EpiVax Company Profile
14.17.2 EpiVax Botulinum Neurotoxins Product Specification
14.17.3 EpiVax Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Anterios
14.18.1 Anterios Company Profile
14.18.2 Anterios Botulinum Neurotoxins Product Specification
14.18.3 Anterios Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Escape Therapeutics
14.19.1 Escape Therapeutics Company Profile
14.19.2 Escape Therapeutics Botulinum Neurotoxins Product Specification
14.19.3 Escape Therapeutics Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Lipella
14.20.1 Lipella Company Profile
14.20.2 Lipella Botulinum Neurotoxins Product Specification
14.20.3 Lipella Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.21 Malvern Cosmeceutics
14.21.1 Malvern Cosmeceutics Company Profile
14.21.2 Malvern Cosmeceutics Botulinum Neurotoxins Product Specification
14.21.3 Malvern Cosmeceutics Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.22 PharmaVital
14.22.1 PharmaVital Company Profile
14.22.2 PharmaVital Botulinum Neurotoxins Product Specification
14.22.3 PharmaVital Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.23 Merz Pharma
14.23.1 Merz Pharma Company Profile
14.23.2 Merz Pharma Botulinum Neurotoxins Product Specification
14.23.3 Merz Pharma Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.24 Transdermal
14.24.1 Transdermal Company Profile
14.24.2 Transdermal Botulinum Neurotoxins Product Specification
14.24.3 Transdermal Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.25 Valeant Pharmaceuticals
14.25.1 Valeant Pharmaceuticals Company Profile
14.25.2 Valeant Pharmaceuticals Botulinum Neurotoxins Product Specification
14.25.3 Valeant Pharmaceuticals Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.26 CNBG
14.26.1 CNBG Company Profile
14.26.2 CNBG Botulinum Neurotoxins Product Specification
14.26.3 CNBG Botulinum Neurotoxins Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Botulinum Neurotoxins Market Forecast (2023-2028)
15.1 Global Botulinum Neurotoxins Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Botulinum Neurotoxins Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Botulinum Neurotoxins Value and Growth Rate Forecast (2023-2028)
15.2 Global Botulinum Neurotoxins Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Botulinum Neurotoxins Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Botulinum Neurotoxins Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Botulinum Neurotoxins Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Botulinum Neurotoxins Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Botulinum Neurotoxins Consumption Forecast by Type (2023-2028)
15.3.2 Global Botulinum Neurotoxins Revenue Forecast by Type (2023-2028)
15.3.3 Global Botulinum Neurotoxins Price Forecast by Type (2023-2028)
15.4 Global Botulinum Neurotoxins Consumption Volume Forecast by Application (2023-2028)
15.5 Botulinum Neurotoxins Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 129 |
| Price : US$ 2450 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 269 |
| Price : US$ 2450 |
Date : Feb 2024 |
| Category : Electronics |
Pages : 261 |
Request Sample 
Request Discount 
Inquire Before Buy
